Patents by Inventor Donna Finch

Donna Finch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING COPD EXACERBATION
    Publication number: 20130149312
    Abstract: This disclosure relates to methods of treating exacerbation of chronic obstructive pulmonary disease (COPD) with antibodies and antagonists to interleukin 1 receptor 1 (IL-1R1) or IL-1?.
    Type: Application
    Filed: April 18, 2011
    Publication date: June 13, 2013
    Applicants: MCMASTER UNIVERSITY, MEDIMMUNE LIMITED
    Inventors: Donna Finch, Anthony Coyle, Martin Stampfli
  • Antibodies to TGF-beta
    Publication number: 20070264255
    Abstract: The present invention relates to antibody molecules, in particular antibody molecules that bind Transforming Growth Factor beta (TGF?), and uses thereof. More particularly, the invention relates to antibody molecules that bind and preferably neutralise TGF?1, TGF?2 and TGF?3, so-called “pan-specific” antibody molecules, and uses of such antibody molecules. Preferred embodiments within the present invention are antibody molecules, whether whole antibody (e.g. IgG, such as IgG1 or IgG4) or antibody fragments (e.g. scFv, Fab, dAb).
    Type: Application
    Filed: January 30, 2007
    Publication date: November 15, 2007
    Inventors: Steven Ledbetter, Celia Hart, Robert Holgate, Lutz Jermutus, Catriona Buchanan, Alexander Duncan, Donna Finch
  • Antibodies to TGF-BETA
    Publication number: 20070134246
    Abstract: The present invention relates to antibody molecules, in particular antibody molecules that bind Transforming Growth Factor beta (TGF?), and uses thereof. More particularly, the invention relates to antibody molecules that bind and preferably neutralise TGF?1, TGF?2 and TGF?3, so-called “pan-specific” antibody molecules, and uses of such antibody molecules. Preferred embodiments within the present invention are antibody molecules, whether whole antibody (e.g. IgG, such as IgG1 or IgG4) or antibody fragments (e.g. scFv, Fab, dAb).
    Type: Application
    Filed: January 30, 2007
    Publication date: June 14, 2007
    Inventors: Steven Ledbetter, Celia Hart, Robert Holgate, Lutz Jermutus, Catriona Buchanan, Alexander Duncan, Donna Finch
  • Antibodies to TGF-beta
    Publication number: 20060251658
    Abstract: The present invention relates to antibody molecules, in particular antibody molecules that bind Transforming Growth Factor beta (TGF?), and uses thereof. More particularly, the invention relates to antibody molecules that bind and preferably neutralise TGF?1, TGF?2 and TGF?3, so-called “pan-specific” antibody molecules, and uses of such antibody molecules. Preferred embodiments within the present invention are antibody molecules, whether whole antibody (e.g. IgG, such as IgG1 or IgG4) or antibody fragments (e.g. scFv, Fab, dAb).
    Type: Application
    Filed: February 8, 2006
    Publication date: November 9, 2006
    Inventors: Steven Ledbetter, Celia Hart, Robert Holgate, Lutz Jermutus, Catriona Buchanan, Alexander Duncan, Donna Finch